Sally C. Medley

Array ( [id] => 2961267 [patent_doc_number] => 05273962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-28 [patent_title] => 'Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site' [patent_app_type] => 1 [patent_app_number] => 8/014723 [patent_app_country] => US [patent_app_date] => 1993-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7196 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/273/05273962.pdf [firstpage_image] =>[orig_patent_app_number] => 014723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010988 [patent_doc_number] => 05354934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-11 [patent_title] => 'Pulmonary administration of erythropoietin' [patent_app_type] => 1 [patent_app_number] => 8/013514 [patent_app_country] => US [patent_app_date] => 1993-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7426 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/354/05354934.pdf [firstpage_image] =>[orig_patent_app_number] => 013514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3027087 [patent_doc_number] => 05316938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-31 [patent_title] => 'Defined media for serum-free tissue culture' [patent_app_type] => 1 [patent_app_number] => 7/991717 [patent_app_country] => US [patent_app_date] => 1992-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5499 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/316/05316938.pdf [firstpage_image] =>[orig_patent_app_number] => 991717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3076941 [patent_doc_number] => 05320950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-14 [patent_title] => 'DNA encoding anticoagulative protein PP4-X, and its preparation and use' [patent_app_type] => 1 [patent_app_number] => 7/985912 [patent_app_country] => US [patent_app_date] => 1992-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3924 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/320/05320950.pdf [firstpage_image] =>[orig_patent_app_number] => 985912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805366 [patent_doc_number] => 05830847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Soluble TGF-.beta.-binding endoglin polypeptides and homodimers' [patent_app_type] => 1 [patent_app_number] => 7/968953 [patent_app_country] => US [patent_app_date] => 1992-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5425 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830847.pdf [firstpage_image] =>[orig_patent_app_number] => 968953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3005827 [patent_doc_number] => 05354665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-11 [patent_title] => 'Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3' [patent_app_type] => 1 [patent_app_number] => 7/959550 [patent_app_country] => US [patent_app_date] => 1992-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7379 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/354/05354665.pdf [firstpage_image] =>[orig_patent_app_number] => 959550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3910097 [patent_doc_number] => 06001649 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production' [patent_app_type] => 1 [patent_app_number] => 7/927391 [patent_app_country] => US [patent_app_date] => 1992-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21229 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001649.pdf [firstpage_image] =>[orig_patent_app_number] => 927391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3095307 [patent_doc_number] => 05314690 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-24 [patent_title] => 'Method and composition for treating IgE-mediated allergies' [patent_app_type] => 1 [patent_app_number] => 7/934553 [patent_app_country] => US [patent_app_date] => 1992-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 8708 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/314/05314690.pdf [firstpage_image] =>[orig_patent_app_number] => 934553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3421672 [patent_doc_number] => 05478925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-26 [patent_title] => 'Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 7/925687 [patent_app_country] => US [patent_app_date] => 1992-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 7105 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/478/05478925.pdf [firstpage_image] =>[orig_patent_app_number] => 925687 [rel_patent_id] =>[rel_patent_doc_number] =>)